| Literature DB >> 36151522 |
Xiao-Qin Wang1,2, Ming Chen2, Liu-Zhi Zeng2, Long-Qian Liu3.
Abstract
BACKGROUND: To observe alterations of fundus microcirculation and retinal thickness in adolescent myopic patients with astigmatism after toric and spherical orthokeratology using optical coherence tomography angiography (OCTA), to explore the effects of orthokeratology on the retinal thickness and choroidal blood flow.Entities:
Keywords: Astigmatism; Choroid; Microcirculation; Myopia; Optical coherence tomography angiography; Orthokeratology; Retinal thickness
Mesh:
Year: 2022 PMID: 36151522 PMCID: PMC9508713 DOI: 10.1186/s12886-022-02572-y
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.086
Fig. 1OCTA map. A: Whole Superior-Hemi, WSH; B: Whole Inferior-Hemi, WIH; C: Fovea, F and Parafovea, Para; D: Superior, S, Inferior, I, Nasal, N, Temporal, T; E: Superior-Hemi, Para SH; F: Inferior-Hemi, Para IH; G: Inside Disc, ID; H: Peripapillary, Peri; I: Superior-Hemi, Peri SH; J: Inferior-Hemi, Peri IH; K: Choriocapillaris flow area centered on the fovea, ChC; L: Foveal avascular zone, FAZ
Participants’ characteristics at baseline
| T group | S group | ||
|---|---|---|---|
| Age (yr) | 11.08 ± 2.04 | 11.29 ± 2.05 | 0.726a |
| Sphere (D) | - 3.00 ± 1.20 | - 1.88(− 5.00 ~ − 0.75) | 0.055b |
| Cylinder (D) | −1.13 (−2.00 ~ − 0.75) | - 0.50(− 1.00 ~ − 0.50) | |
| AL (mm) | 24.85 ± 1.01 | 24.54 ± 0.71 | 0.229a |
| Kf (D) | 42.93 ± 1.16 | 42.63 ± 1.36 | 0.414a |
| Ks (D) | 44.72 ± 1.22 | 43.55 ± 1.43 | |
| WTW (mm) | 12.35 (11.60 ~ 12.80) | 12.03 ± 0.35 | 0.063b |
| IOP (mmHg) | 16.29 ± 2.40 | 17.08 ± 2.28 | 0.248a |
| Schirmer test (mm) | 21.75 ± 2.36 | 19.46 ± 3.50 | |
| ECD (cells/mm2) | 2970.86 ± 165.15 | 2875.58 ± 175.53 | 0.059a |
Significant P values are in bold
Values are shown as mean ± standard deviation and median (range)
aPaired t-test
bWilcoxon signed-rank test
AL axial length, K flat keratometry, K steep keratometry, WTW white to white, IOP intraocular pressure, ECD Endothelial cell density
Vessel density, FAZ and ChC before and after orthokeratology in two group
| T group | S group | |||||
|---|---|---|---|---|---|---|
| Baseline | three months | Baseline | three months | |||
| SCP vessel density (%) | ||||||
| Whole area | 48.7 ± 2.1 | 49.2 ± 2.6 | 0.459a | 48.8 ± 2.3 | 49.7 ± 2.4 | 0.171a |
| Superior-Hemi | 48.5 ± 1.9 | 49.0 ± 2.9 | 0.551a | 48.8 ± 2.0 | 49.8 ± 2.2 | 0.121a |
| Inferior-Hemi | 49.0 (40.9–52.7) | 49.3 ± 2.2 | 0.616b | 48.8 ± 2.8 | 49.8 ± 2.5 | 0.220a |
| Fovea | 19.7 (14.2–30.2) | 23.3 ± 5.0 | 19.8 ± 5.3 | 21.6 ± 5.4 | 0.103a | |
| Parafovea | 50.6 ± 2.3 | 52.7 ± 2.7 | 51.2 ± 2.5 | 53.3 ± 2.1 | ||
| Superior-Hemi | 51.4 ± 1.9 | 51.6 ± 3.6 | 0.864a | 51.6 ± 2.3 | 52.5 ± 2.6 | 0.210a |
| Inferior-Hemi | 51.3 ± 2.5 | 52.2 ± 2.8 | 0.240a | 51.9 ± 3.0 | 53.3 ± 2.5 | 0.102a |
| Tempo | 50.5 (41.8–54.9) | 50.6 ± 3.3 | 0.658b | 50.6 ± 2.9 | 51.9 ± 2.4 | 0.126a |
| Superior | 52.5 ± 2.3 | 52.9 ± 3.5 | 0.655a | 52.4 ± 2.9 | 54.0 ± 2.7 | 0.098a |
| Nasal | 50.7 ± 2.3 | 51.2 (39.1 ~ 55.7) | 0.943b | 51.0 ± 2.4 | 51.8 ± 2.9 | 0.302a |
| Inferior | 51.8 (41.7–57.1) | 53.3 ± 3.6 | 0.189b | 53.0 (40.8–57.1) | 54.2 ± 2.7 | 0.089b |
| DCP vessel density (%) | ||||||
| Whole area | 53.5 ± 3.4 | 55.7 ± 2.6 | 52.8 ± 3.0 | 54.8 ± 2.8 | ||
| Superior-Hemi | 54.7 ± 3.4 | 55.3 ± 3.3 | 0.464a | 53.5 ± 3.1 | 54.9 ± 3.4 | 0.052a |
| Inferior-Hemi | 54.8 (45.2–59.2) | 54.5 ± 2.6 | 0.573b | 52.7 ± 3.1 | 54.0 ± 2.9 | 0.052a |
| Fovea | 36.3 ± 4.5 | 39.3 ± 6.5 | 34.2 ± 5.6 | 35.3 ± 5.1 | 0.340a | |
| Parafovea | 56.2 ± 3.2 | 57.3 ± 3.2 | 0.113a | 55.0 ± 2.7 | 57.0 ± 2.9 | |
| Superior-Hemi | 56.7 ± 3.1 | 57.2 ± 3.8 | 0.465a | 55.7 ± 2.8 | 57.1 ± 3.5 | |
| Inferior-Hemi | 56.0 ± 3.7 | 57.0 ± 2.9 | 0.217a | 54.9 ± 2.8 | 56.4 ± 2.9 | |
| Tempo | 56.7 ± 3.1 | 57.3 ± 2.7 | 0.367a | 55.8 ± 2.6 | 57.0 ± 2.8 | |
| Superior | 56.9 ± 3.5 | 57.7 ± 3.6 | 0.319a | 55.6 ± 3.0 | 57.1 ± 3.9 | 0.119a |
| Nasal | 56.6 ± 2.8 | 57.5 ± 3.0 | 0.088a | 55.8 ± 2.8 | 56.8 ± 3.7 | 0.101a |
| Inferior | 55.4 (45.5–61.2) | 56.2 ± 3.9 | 0.297b | 54.2 ± 3.3 | 55.9 ± 3.0 | 0.027a |
| RPC vessel density (%) | ||||||
| Whole area | 49.6 ± 2.1 | 51.3 (49.1–56.3) | 49.3 ± 2.2 | 50.9 ± 2.1 | 0.005a | |
| Inside disc | 50.9 ± 5.5 | 56.5 (39.1–61.8) | 51.3 ± 4.6 | 55.2 ± 3.7 | ||
| Peripapillary | 52.0 ± 2.5 | 52.7 ± 2.4 | 0.367a | 51.9 ± 2.3 | 52.3 ± 2.1 | 0.478a |
| Superior-Hemi | 52.3 ± 2.6 | 53.0 ± 2.1 | 0.344a | 52.3 ± 2.2 | 52.6 (42.4–57.7) | 0.568b |
| Inferior-Hemi | 51.8 ± 2.9 | 53.0 ± 3.1 | 0.224a | 51.9 ± 2.7 | 52.1 ± 2.6 | 0.811a |
| FAZ (mm2) | 0.27 ± 0.06 | 0.24 ± 0.07 | 0.31 ± 0.07 | 0.27 ± 0.07 | ||
| ChC (mm2) | 2.18 ± 0.10 | 2.26 ± 0.10 | 2.19 ± 0.08 | 2.27 (2.11–2.80) | ||
Significant P values are in bold
Values are shown as mean ± standard deviation and median (range)
aPaired t-test
bWilcoxon signed-rank test
FAZ foveal avascular zone, ChC choriocapillaris, SCP superficial capillary plexus, DCP deep capillary plexus, RPC radial peripapillary capillary
Vessel density, FAZ, ChC and SFChT of two age groups before and after toric orthokeratology
| 8-11y ( | 12-15y ( | |||||
|---|---|---|---|---|---|---|
| Baseline | three months | Baseline | three months | |||
| SCP vessel density(%) | ||||||
| Whole area | 48.6 ± 2.4 | 49.0 ± 2.5 | 0.679a | 48.8 ± 1.9 | 49.3 ± 2.8 | |
| Fovea | 19.8 (16.0–28.3) | 23.5 ± 4.4 | 19.7 ± 4.4 | 23.1 ± 5.8 | 0.060a | |
| Parafovea | 50.6 ± 2.4 | 52.2 ± 2.9 | 0.147a | 50.7 ± 2.4 | 53.1 ± 2.6 | |
| DCP vessel density (%) | ||||||
| Whole area | 52.1 ± 3.0 | 55.2 ± 2.4 | 0.005a | 54.9 ± 3.3 | 56.1 ± 2.9 | |
| Fovea | 37.9 ± 5.4 | 40.2 ± 7.1 | 0.145a | 34.7 ± 2.9 | 38.4 ± 6.2 | 0.054a |
| Parafovea | 55.4 ± 2.9 | 56.3 ± 3.0 | 0.507a | 57.0 ± 3.5 | 58.4 ± 3.2 | |
| RPC vessel density(%) | ||||||
| Whole area | 49.1 ± 1.6 | 51.7 (50.5–56.3) | 50.1 ± 2.4 | 51.4 ± 2.2 | 0.075a | |
| Inside disc | 52.0 ± 4.9 | 56.0 ± 3.7 | 49.8 ± 6.0 | 53.4 ± 6.2 | ||
| FAZ (mm2) | 0.25 ± 0.07 | 0.24 ± 0.07 | 0.397a | 0.29 ± 0.06 | 0.20 (0.16–0.37) | 0.050b |
| ChC (mm2) | 2.24 (2.02–2.27) | 2.18 ± 0.09 | 0.084b | 2.19 ± 0.11 | 2.28 ± 0.11 | |
| SFChT (μm) | 282.7 ± 23.2 | 298.4 ± 21.0 | 291.3 ± 30.3 | 304.6 ± 26.9 | ||
Significant P values are in bold
Values are shown as mean ± standard deviation and median (range)
aPaired t-test
bWilcoxon signed-rank test
FAZ foveal avascular zone, ChC choriocapillaris, SFChT subfoveal choroidal thickness, SCP superficial capillary plexus, DCP deep capillary plexus, RPC radial peripapillary capillary
Vessel density, FAZ, ChC and SFChT of two age groups before and after spherical orthokeratology
| 8-11y( | 12-15y( | |||||
|---|---|---|---|---|---|---|
| Baseline | three months | Baseline | three months | |||
| SCP vessel density(%) | ||||||
| Whole area | 49.3 ± 2.1 | 49.0 ± 2.3 | 0.792a | 48.4 ± 2.5 | 50.4 ± 2.3 | |
| Fovea | 21.2 ± 5.3 | 21.4 ± 6.5 | 0.951a | 18.6 ± 5.2 | 21.8 ± 4.4 | |
| Parafovea | 51.7 ± 2.6 | 52.6 ± 1.9 | 0.448a | 50.8 ± 2.4 | 53.9 ± 2.2 | |
| DCP vessel density(%) | ||||||
| Whole area | 51.6 (0.3–57.0) | 54.3 ± 3.2 | 53.3 ± 3.7 | 55.1 ± 2.5 | ||
| Fovea | 36.4 ± 6.6 | 36.4 ± 5.7 | 0.978a | 32.4 ± 4.1 | 34.3 ± 4.6 | 0.060a |
| Parafovea | 54.2 ± 1.9 | 6.1 ± 2.7 | 0.074a | 55.6 ± 3.2 | 57.7 ± 3.0 | |
| RPC vessel density(%) | ||||||
| Whole area | 49.4 ± 2.1 | 50.8 ± 1.9 | 0.088a | 49.2 ± 2.3 | 51.0 ± 2.3 | |
| Inside disc | 52.6 ± 5.5 | 55.9 ± 2.5 | 0.151a | 50.3 ± 5.0 | 54.5 ± 4.5 | |
| FAZ (mm2) | 0.29 ± 0.08 | 0.27 ± 0.07 | 0.33 ± 0.06 | 0.27 ± 0.07 | ||
| ChC (mm2) | 2.17 ± 0.07 | 2.24 ± 0.06 | 2.25 (2.06–2.30) | 2.31 (2.11–2.80) | ||
| SFChT (μm) | 274.5 ± 30.1 | 287.5 ± 26.1 | 272.8 ± 28.7 | 288.9 ± 30.6 | ||
Significant P values are in bold
Values are shown as mean ± standard deviation and median (range)
aPaired t-test
bWilcoxon signed-rank test
FAZ foveal avascular zone, ChC choriocapillaris, SFChT subfoveal choroidal thickness, SCP superficial capillary plexus, DCP deep capillary plexus, RPC radial peripapillary capillary
Thicknesses (μm) of macular, choroid, and RNFL before and after orthokeratology in two group
| T group | S group | |||||
|---|---|---|---|---|---|---|
| Baseline | three months | Baseline | three months | |||
| Whole area | 309.7 ± 11.7 | 314.9 ± 10.9 | 313.6 ± 15.1 | 319.9 ± 16.1 | ||
| Superior-Hemi | 310.5 ± 12.2 | 316.0 ± 11.2 | 0.053a | 313.3 ± 15.1 | 319.6 ± 15.3 | |
| Inferior-Hemi | 308.5 ± 11.7 | 313.8 (281.0–327.0) | 314.8 ± 15.7 | 317.6 ± 16.0 | 0.276a | |
| Fovea | 250.5 ± 14.9 | 251.2 ± 12.9 | 0.807a | 247.6 ± 16.8 | 245.8 ± 12.5 | 0.757a |
| Parafovea | 317.8 ± 11.7 | 325.0 ± 12.2 | 323.1 ± 15.6 | 329.2 ± 15.4 | ||
| Superior-Hemi | 320.2 ± 13.3 | 325.6 ± 12.3 | 0.054a | 325.6 ± 16.3 | 329.1 ± 16.3 | 0.110a |
| Inferior-Hemi | 317.6 ± 11.8 | 323.9 ± 11.6 | 323.3 ± 15.1 | 327.1 ± 16.5 | 0.097a | |
| Temporal | 309.7 ± 13.5 | 315.6 ± 12.2 | 316.0 ± 14.4 | 320.0 ± 16.2 | 0.096a | |
| Superior | 322.4 ± 13.7 | 328.5 ± 12.7 | 328.2 ± 17.1 | 332.8 ± 16.6 | 0.052a | |
| Nasal | 324.5 ± 12.0 | 327.6 ± 11.7 | 0.213a | 329.2 ± 16.6 | 331.3 ± 16.9 | 0.329a |
| Inferior | 318.6 ± 11.8 | 323.8 ± 12.2 | 324.3 ± 15.6 | 328.3 ± 17.0 | 0.110a | |
| SFChT | 287.0 ± 26.8 | 301.5 ± 23.8 | 273.6 ± 28.7 | 288.3 ± 28.0 | ||
| pRNFL | 129.5 (108–150) | 123.5 (108–156) | 0.166b | 127.0 (106–181) | 126.1 ± 12.3 | |
Significant P values are in bold
Values are shown as mean ± standard deviation and median (range)
aPaired t-test
bWilcoxon signed-rank test
RNFL retinal nerve fiber layer, SFChT subfoveal choroidal thickness, pRNFL peripapillary retinal nerve fiber layer